《大行報告》摩通:匯控(00005.HK)「自救計劃」支持RoTE達雙位數至關重要
摩根大通發表研究報告指,匯控(00005.HK)過去十年的「自救計劃」,對支持RoTE達雙位數至關重要,例如減少風險加權資產(RWA)及成本優化等,即使政策利率正常化至約2.5%,亦支持約11%的RoTE。該行維持其「增持」評級,目標價80元。
該行預計,匯控今年標準化ROE為14.9%,較疫情前擴大880個基點。其中530個基點是透過結構性改革計劃實現。該行又預期,匯控標準化RoTE將從10年平均值的8.1%提高至今年的16.4%,並在明年降至14.5%和2025年的12.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.